Results 131 to 140 of about 948,913 (337)
Toward market design in practice: a progress report. [PDF]
Jpn Econ Rev (Oxf), 2022 Kojima F, Odahara H.
europepmc +1 more source
Molecular Oncology, EarlyView.The authors conducted a retrospective study of 94 patients with advanced cancer who underwent next‐generation sequencing (NGS) gene panel analysis and received targeted treatments when applicable. Results further support evidence indicating that molecular profiling provides clinical benefit.
Michaël Dang +3 more
wiley +1 more source
California Agriculture, 1951 Part II of a two-part progress report. Part I of this progress report, published in the February 1951 issue of California Agriculture, described the marked improvement observed in the vegetative characteristics of lemon trees receiving soil applications ...
D Aldrich, J Coony
doaj
Molecular Oncology, EarlyView.Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou +11 more
wiley +1 more source
Index to the hydrographic progress reports of the United States Geological survey, 1888 to 1903 [PDF]
, 1905 J.C. Hoyt, Beatrice Dawson Wood
openalex +1 more source
Molecular Oncology, EarlyView.Patient‐derived xenografts (PDXs) can be improved by implantation of a humanized niche. We tested different biomaterials and approaches, and demonstrate that the combination of an injectable biomaterial for scaffold creation plus an intravenous route for acute myeloid leukemia (AML) xenotransplantation provide the most convenient and robust approach to
Daniel Busa +13 more
wiley +1 more source